Lexeo Therapeutics, Inc. Common Stock
(LXEO - NASDAQ)
5,62 USD
📋 Profilo Aziendale

Lexeo Therapeutics, Inc. operates as a clinical-stage genetic medicine company that focuses on hereditary and acquired diseases.

|